Archives
Dupilumab Tied to Fewer Exacerbations in COPD With Type 2 Inflammation
Increase seen in prebronchodilator forced expiratory volume in one second with dupilumab versus placebo at weeks 12, 52
Semaglutide Has Lasting Benefit for Weight Loss
Second study shows cardiovascular benefit for semaglutide, regardless of weight loss
Survival Benefit for Cancer Trial Participants Does Not Persist in Adjusted Analyses
Survival benefits disappear when only high-quality studies are pooled and with adjustment for potential publication bias
Social Determinants of Health Impact Poststroke Mortality Risk
Strongest associations seen for educational and income attainment
Fezolinetant Safe, Effective for Moderate-to-Severe Menopause Hot Flashes
Benefits seen within days for both frequency and severity of symptoms
Arm Fat May Predict Spinal Fracture Risk
Higher fat mass in the arms tied to lower bone quality measured by trabecular bone score
Prehospital Reduction in BP Does Not Improve Stroke Outcomes
Findings seen in patients with suspected acute stroke with elevated systolic blood pressure
Individuals With BAP1 Have High Rate of Nail Abnormalities
Almost all patients with nail involvement had polydactylous involvement with onychopapillomas
Bisoprolol Does Not Reduce Exacerbations in At-Risk COPD Patients
No reduction seen in number of self-reported exacerbations treated with oral corticosteroids, antibiotics, or both
Male, Female V1421 Carriers Face Similar Risk for Heart Failure Hospitalization
Carriers face similar and substantial risk for heart failure hospitalization, mainly with reduced ejection fraction
